Audentes Therapeutics Inc buy melinda
Start price
25.04.17
/
50%
€13.07
Target price
26.04.17
€15.33
Performance (%)
9.18%
End price
26.04.17
€14.27
Summary
This prediction ended on 26.04.17 with a price of €14.27. With a performance of 9.18%, the BUY prediction by melinda for Audentes Therapeutics Inc closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Audentes Therapeutics Inc | - | - | - | - |
| iShares Core DAX® | 1.085% | -0.846% | 12.464% | 58.472% |
| iShares Nasdaq 100 | -1.665% | -3.306% | 1.502% | 84.473% |
| iShares Nikkei 225® | 3.863% | 6.308% | 22.272% | 56.185% |
| iShares S&P 500 | 0.111% | -1.337% | 1.101% | 58.320% |
Comments by melinda for this prediction
In the thread Audentes Therapeutics Inc diskutieren
Biotech
Audentes Therapeutics, Inc. ist ein Biotechnologie - Unternehmen, das die Entwicklung und Vermarktung von Gen - Therapie - Produkten für Patienten mit seltenen und schweren Krankheiten , die durch einzelne Genprodukte verpflichtet sind defects.Its AT001 für die Behandlung von X-chromosomale Myopathie myotubulären
Stopped prediction by melinda for Audentes Therapeutics Inc
Audentes Therapeutics Inc
Start price
Target price
Perf. (%)
€24.98
12.10.18
12.10.18
€31.12
22.01.19
22.01.19
-15.17%
22.01.19
22.01.19
Audentes Therapeutics Inc
Start price
Target price
Perf. (%)
€31.74
16.05.18
16.05.18
€34.28
17.05.18
17.05.18
8.14%
17.05.18
17.05.18
Audentes Therapeutics Inc
Start price
Target price
Perf. (%)
€26.32
17.03.18
17.03.18
€32.65
11.04.18
11.04.18
26.17%
11.04.18
11.04.18